Higher doses may lead to more significant reductions in blood sugar levels but could also increase the risk of side effects
For high resolution scans of selected regions, a LaVision ultramicroscope II setup (Miltenyi Biotec, Bergisch Gladbach, Germany) equipped with a pco.edge 4.2 sCMOS camera (PCO imaging AG, Kelheim, Germany), SuperK EXTREME supercontinuum white-light laser EXR-15 (NKT Photonics, Birkerd, Denmark) and MV PLAPO 2XC (Olympus, Tokyo, Japan) objective lens was used
Preclinical studies and early-phase trials have demonstrated that semaglutide may reduce amyloid-beta accumulation, mitigate tau pathology, and improve cognitive performance in Alzheimers disease models [90]
doi: 10.2337/db06-1491 12 CaniP
No significant prolactin elevation occurs, eliminating the gynecomastia concerns associated with GHRP-2 at higher doses